Back
Immunovant, Inc. 10K Form
Sell
30
IMVT
Immunovant, Inc.
Last Price:
$26.53
Seasonality Move:
-11.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IMVT News And Ratings
See the #1 stock for the next 7 days that we like better than IMVT
IMVT Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-92.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.85 |
| Price / Book: | 5.31 |
Profitability
| EPS (TTM): | -2.68230 |
|---|---|
| Net Income (TTM): | $-464.2M |
| Gross Margin: | $-377K |
| Return on Equity: | -73.12% |
| Return on Assets: | -66.41% |
Immunovant, Inc. Earnings Forecast
Key Immunovant, Inc. Financial Ratios
-
Per Share Earnings over the last 7 years have been positive in 1 years.
Immunovant, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IMVT |
| CUSIP: | 45258J |
| Website: | immunovant.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 15.74 |
| Quick Ratio: | 15.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IMVT Technical Analysis vs Fundamental Analysis
Sell
30
Immunovant, Inc. (IMVT)
is a Sell
Is Immunovant, Inc. a Buy or a Sell?
-
Immunovant, Inc. stock is rated a SellThe current Immunovant, Inc. [IMVT] share price is $25.75. The Score for IMVT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.